Bit Capital Gmb H Cardiff Oncology, Inc. Transaction History

Bit Capital Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$2.31 - $5.35 $584,626 - $1.35 Million	-253,085 Closed	0 $0
Q3 2024 Feb 12, 2025	SELL	$2.05 - $2.77 $86,987 - $117,539	-42,433 Reduced 14.36%	253,085 $676 Million
Q2 2024 Feb 12, 2025	BUY	$2.22 - $5.89 $131,732 - $349,506	59,339 Added 25.12%	295,518 $656 Million
Q1 2024 Feb 12, 2025	BUY	$1.46 - $5.91 $344,821 - $1.4 Million	236,179 New	236,179 $1.26 Billion

12.7M

813K

91.1K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $177M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.